lobbying_activities: 1725602
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1725602 | d25f517f-5613-4316-90c3-92651ad3ead8 | 3T | RED+BLUE STRATEGIES | 400693064 | HOSPIRA | 2015 | third_quarter | PHA | Issues related to the naming of biosimilars as they enter into the national prescription drug marketplace. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 1 | 2015-09-09T15:21:43.843000-04:00 |